Dr Yael Mauer Details Underlying Mechanisms of GLP-1s, Patient Benefits

Yael Mauer, MD, MPH, discusses the patient population who benefits most from interventions with glucagon-like peptide-1 (GLP-1) therapies and explores the underlying mechanisms at work.

Related Keywords

United States ,American ,Yael Mauer ,Institute For Value ,Department Of Endocrinology ,Value Based Medicine ,Cleveland Clinic ,American Journal ,